tuberculosis

Documents about tuberculosis

• Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment#908784ClinicalTrials.gov
• BCG Revaccination in Children and Adolescents#279556ClinicalTrials.gov
• Global tuberculosis report 2016#184010WHO IRIS
• Diagnosis of Active Tuberculosis by ELISPOT#805721ClinicalTrials.gov
• Treatment Duration for Abdominal Tuberculosis#902705ClinicalTrials.gov
• Respiratory Health and Wellbeing Post Pulmonary Tuberculosis#858967ClinicalTrials.gov
• Point-of-care Triage Test for Active Tuberculosis#217202ClinicalTrials.gov
• A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis#28367ClinicalTrials.gov
• Positron Emission Tomography in Extrapulmonary Tuberculosis#848102ClinicalTrials.gov
• Improving the Detection of Active Tuberculosis in Accident and Emergency Departments#867245ClinicalTrials.gov
• Lifetime burden of disease due to incident tuberculosis : a global reappraisal including post-tuberculosis sequelae#470000SUNScholar
• Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients#394585ClinicalTrials.gov
• Follow up of Autoantibodies in Active Tuberculosis#811280ClinicalTrials.gov
• Innovation in Tuberculosis#148799ClinicalTrials.gov
• Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults#290854ClinicalTrials.gov
• Micronutrient Supplementation in in Paediatric Pulmonary Tuberculosis#849487ClinicalTrials.gov
• Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence#869524ClinicalTrials.gov
• LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea#813277ClinicalTrials.gov
• Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis#915908ClinicalTrials.gov
• Preventive Therapy for Tuberculosis in HIV Infected Persons#918537ClinicalTrials.gov
• Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection#873511ClinicalTrials.gov
• Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection#878082ClinicalTrials.gov
• Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis#881417ClinicalTrials.gov
• Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis#914528ClinicalTrials.gov
• Tuberculosis Cohort Avicenne Hospital#878501ClinicalTrials.gov
• Doxycycline in Human Pulmonary Tuberculosis#917086ClinicalTrials.gov
• WHO operational handbook on tuberculosis: module 2: screening: systematic screening for tuberculosis disease#223731WHO IRIS
• Detection of Mycobacterium Tuberculosis in Blood of TB Patients and Their Contacts in Uganda#261322ClinicalTrials.gov
• The Role of Tuberculosis in Chronic Obstructive Lung Disease#845002ClinicalTrials.gov
• Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults#854281ClinicalTrials.gov
• Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients#856443ClinicalTrials.gov
• Identifying pediatric extrapulmonary tuberculosis through an active screening program: Findings and programmatic implications from Bangladesh#469496PLOS
• The public health utility of whole genome sequencing: Insights from a tuberculosis outbreak in Australia and perspectives of public health professionals#679660PLOS
• Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis#800791ClinicalTrials.gov
• Incidence of Tuberculosis in Patients With Autoimmune Rheumatic Diseases#812539ClinicalTrials.gov
• Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)#836653ClinicalTrials.gov
• Linezolid Dosing Strategies in Drug-Resistant TB#810954ClinicalTrials.gov
• Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis#811598ClinicalTrials.gov
• Poor In Vitro Fertilisation Outcomes in Genital Tuberculosis - Case Report#814040ClinicalTrials.gov
• Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081#872092ClinicalTrials.gov
• Latent Tuberculosis in Healthcare Workers - the Reality of a Portuguese Tertiary Hospital#874590ClinicalTrials.gov
• A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets#905526ClinicalTrials.gov
• Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A#290834ClinicalTrials.gov
• Latent Tuberculosis in Type 2 Diabetes#318557ClinicalTrials.gov
• Deworming Against Tuberculosis#860435ClinicalTrials.gov
• Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)#28554ClinicalTrials.gov
• Análisis de la expresión de genes potencialmente involucrados en latencia de Mycobacterium tuberculosis#225195Repositorio institucional Séneca
• Pulmonary Aspergillosis in Tuberculosis Patients#674918ClinicalTrials.gov
• Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection#811144ClinicalTrials.gov
• Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis#868134ClinicalTrials.gov

Related topics